Summary The natural history of transitional cell carcinoma (TCC) of the urinary bladder is somewhat variable, with a significant number of tumour recurrences that occasionally evolve towards an infiltrating disease. The aim of this study was to investigate the presence of human papillomavirus (HPV) DNA in 76 TCC specimens, and then correlate such findings with the overall patient survival. However, other classical prognostic clinical and pathological variables such as pathological grade and stage, koilocytosis, age and sex were also tested. HPV DNA was investigated by means of the highly sensitive polymerase chain reaction (PCR). DNA primers specific for HPV types 6, 11, 16 and 18 were used. Our results showed that 7 (9.21%) out of 76 such cases were reactive for HPV 16 DNA; one of them also reacted with HPV 6 DNA. The statistical analysis was done by the Kaplan-Meier method, Wilcoxon's generalised test for studying the differences in survival curves and Cox's regression analysis for independent prognostic factors. A significant P-value was found for pathological grade (P<0.0001) and stage (P<0.0001), HPV 16 DNA (P = 0.0418) and koilocytosis (P = 0.0140). Thus, pathological grade was the only independent factor in the bladder cancer survival. These observations may prove useful in prognostic stratification of patients with TCC of the bladder.
The presence of human papillomavirus (HPV) DNA has been reported most frequently in association with cervical dysplasias which can progress to malignancies, and benign condylomata acuminata (Stoler et al., 1992; Donalson et al., 1993) . Recent studies indicate that some HPVs are associated with bladder carcinoma (Del Mistro et al., 1988; Kitamura et al., 1988; Querci Della Rovere et al., 1988; Bryant et al., 1991; Anwar et al., 1992; Chetsanga et al., 1992; LopezBeltran et al., 1992a; Furihata et al., 1993; Chang et al., 1994; Lopez-Beltran and Munioz, 1995) . However, the exact incidence of HPV DNA involved in TCC of the bladder remains controversial (Chang et al., 1994; Lopez-Beltran and Muiioz, 1995) , since the reported incidence varies between 2.5% and 62% (Anwar et al., 1992; Chetsanga et al., 1992; Lopez-Beltran et al., 1992a; Lopez-Beltran and Mufioz 1995) . Negative results have been reported by Chang et al. (1994) and Ashfaq and Vuitch (1994) . The prognostic implication of HPV infection in bladder cancer survival was suggested by Lopez-Beltran et al. (1992a) and Furihata et al. (1993) , using non-isotopic DNA in situ hybridisation.
The aim of the present research was to investigate HPV incidence in 76 TCC specimens, using polymerase chain reaction (PCR) analysis, and then to correlate such findings with the overall patient survival. This study also included other classic prognosticators, such as the pathological grade and stage, patient age and sex, and koilocytosis. An attempt is also made to ascertain their possible prognostic implication in bladder cancer survival.
Materials and methods
The study group consisted of 76 unselected and consecutive cases of TCC of the urinary bladder received at Reina Sofia University Hospital (Cordoba, Spain). All 76 patients underwent transurethral resection (TUR). Their mean age was 66.57 ± 1.17. Fourteen patients were female. Selected tissue specimens from all biopsies, formalin-fixed paraffin-embedded, were analysed for pathological grade and stage. All cases were followed over 5 years. Koilocytosis in TCC was evaluated following the criteria proposed by Hartveit et al. (1992) .
Sample preparation for PCR The paraffin-embedded tissues for PCR analysis were cut into 5-10m thin sections. To prevent contamination from one paraffin block to another, the knife and the microtome specimen holder were carefully cleaned with xylene after each specimen had been processed. To extract DNA, each section was placed into Eppendorf tubes and the paraffin removed twice with xylene and washed once with 0.5 ml of 100% ethanol to remove the solvent. The samples were then dried and resuspended in 300 eLI of digestion buffer (50 mM Tris pH 8.5; 1 mM EDTA; 0.5% Tween 20 and 200 1gml-' of proteinase K), and incubated for 6 h at 55°C. (Perkin-Elmer, CT, USA) programmed for 40 cycles of DNA denaturation (95°C), primer annealing (65°C) and template extension (72°C). In the last cycle the extension step was 7 min. Amplified DNA fragments were hybridised with specific [32P]ATP end-labelled probes. The complexes were electrophoresed in 12% SDS/PAGE gels, which were dried and exposed to XAR film for different periods of time. Primers PCO3 and PCO4 which amplified a 110 bp fragment of the human P-globin gene, were included as controls for the amount of DNA analysed. Necessary precautions to avoid cross-contamination were taken at all stages of extraction and amplification (Kwok and Higuchi, 1989) .
Statistical analysis
The statistical analysis was undertaken using the life test procedure. Univariate analysis of cancer-corrected 5 year survival (defined as death from or with bladder cancer) was done according to the Kaplan-Meier method (Kaplan and Meier, 1958) . Differences between survival curves were estimated by the Wilcoxon test (Gehan, 1962) . In addition, independent prognostic factors were sought by Cox regression analysis (Cox, 1972) . A P-value below 0.05 was regarded as being statistically significant.
Results
The selected variables representative of the 76 TCCs included in this study are illustrated in (Lopez-Beltran et al., 1994) . The prognosis of bladder cancer seems to be related to pathological factors such as tumour grade and stage, although the immunohistochemistry of cell and tumour markers as well as flow cytometric analysis of abnormalities in DNA content have also been considered prognostically significant (LopezBeltran et al., 1992b) . The purpose of this paper was to determine whether or not the finding of HPV DNA in TCC has additional prognostic value in patient survival.
HPVs are known to infect man and although most of these proliferations are benign, some may become malignant, and this malignant transformation is related to HPV type (Howley, 1991) . In the genitourinary tract, HPV types 6/11 are most commonly associated with genital condylomata acuminata (Del Mistro, 1988) , whereas types 16 and 18 are associated with dysplasias and carcinomas (Chang, 1990) . In TCC most HPVs were reported in a small number of patients with an immunodeficient status, (Kitamura, 1988; Querci Della Rovere, 1988 Ashaq and Vuitch (1994) (Table IV) . In addition, HPV 16/18 DNA detected by means of non-isotopic in situ hybridisation has been related with a poor survival (Lopez-Beltran et al., 1992a; Furihata et al., 1993) . Our results found a 9.2% incidence of HPV 16 DNA in TCC. Such differences could be explained by methodological reasons (Ashfaq and Vuitch, 1994) . In fact, type and time of fixation have been considered important parameters for preservation of DNA (Greer et al., 1991; Karlsen et al., 1994) . However, the finding presented here of a significant relationship between the detection of HPV 16 DNA and reduced patient survival, using PCR analysis confirmed previous reports on poor survival of TCC cases presenting with high-risk HPV DNA (Lopez-Beltran et al., 1992a; Furihata et al., 1993) detected by using in situ hybridisation. Taken together these results could indicate an additional prognostic value of viral infection in bladder cancer, although pathological grade is the only independent parameter in the survival of bladder cancer as showed by our results. This is in agreement with the finding that most patients with TCC (71.4%) associated with HPV 16 DNA were of high grade. Such results are of interest since pathological grade remains an important prognostic parameter in survival of patients with TCC of the urinary bladder. Finally, we found koilocytosis to be significant in patient survival, which could be related to the increasing incidence of koilocytosis concomitant with increasing pathological grade.
